Neuromod raises $6.2m in Series A

Neuromod said today it raised $6.2 million (EU€5.5 million) in a Series A round of financing, with fund slated to support its mutebutton bi-modal neuromodulation device for patients with chronic tinnitus. Funds from the round came from venture capital firm Fountain Healthcare Partners, the Dublin-based company said. “Neuromod is delighted to announce this investment, which will help us to advance our unique chronic tinnitus treatment technology. As an emerging company we welcome the support and knowledge offered to us from partnering with an experienced international life sciences venture capital fund such as Fountain Healthcare Partners. We are also particularly grateful for the ongoing support we have received from our manufacturing partners, M&M Qualtech and Molex, and from Enterprise Ireland, which enable innovative Irish companies, like Neuromod, to grow and succeed on the international stage,” CEO Dr Ross O’Neill said in prepared remarks. The mutebutton is a handheld bi-modal neuromodulation device device that helps the brain distinguish between real and phantom noises through audio and tongue stimulation. The system promotes neur0plasticity in areas of the brain associated with tinnitus, the company said. “Neuromod is an exciting company, with the potential to offer a superior treatment to and improve the quality of life of the millions of patients suffering with chronic tinnitus. The company has a proprietary neuromodulation tech...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Clinical Trials Neuromodulation/Neurostimulation Neuromod Devices Source Type: news

Related Links:

This study used an operant conditioning animal model to examine the interaction between tinnitus and auditory vigilant attention as well as auditory selective attention. Tinnitus was induced in 90-day-old rats by a unilateral exposure to band-limited noise (120 dB, SPL). Tinnitus testing began 90 days following exposure; afterward animals were divided into 3 groups: Unexposed controls without tinnitus, Exposed without tinnitus, and Exposed with tinnitus. Tinnitus was evident in the vicinity of 20 kHz. Vigilant attention was quantified by the behavioral (operant) response to unpredictable sound transitions signaling changes...
Source: Neuroscience - Category: Neuroscience Source Type: research
CONCLUSION: Dural arteriovenous fistula is an uncommon intracranial vascular malformation rarely seen by otolaryngologists, with pulsatile tinnitus being the usual presentation. To our knowledge, this is the first reported case of dural arteriovenous fistula presenting with conductive hearing loss and otalgia. PMID: 30322412 [PubMed - as supplied by publisher]
Source: Journal of Laryngology and Otology - Category: ENT & OMF Tags: J Laryngol Otol Source Type: research
Conditions:   Tinnitus;   Noise Induced Tinnitus;   Tinnitus, Subjective;   Tinnitus, Objective;   Tinnitus Aggravated;   Tinnitus, Pulsatile;   Tinnitus, Spontaneous Oto-Acoustic Emission;   Tinnitus, Clicking;   Tinnitus, Tensor Tympani Induced Intervention:   Behavioral: Meditation Sponsors:   State University of New York at Buffalo;   University at Buffalo Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Objective and subjective tinnitus can often be differentiated based on comprehensive history, physical examination, and audiogram. Examples of objective tinnitus include vascular abnormalities, palatal myoclonus, patulous eustachian tube, and stapedial/tensor tympani muscle spasm. Subjective tinnitus is usually associated with hearing loss. Rarely, tinnitus is the result of an underlying condition. In these cases, imaging and additional testing may be indicated. Classification of the type, quality, and intensity of tinnitus is helpful in the work-up and treatment of tinnitus. Treatment modalities include cognitive behavior...
Source: Medical Clinics of North America - Category: Primary Care Authors: Source Type: research
ConclusionWe believe the etiology of meningioma in our patients started at childhood and progress to this giant status. We therefore suggest that neurosurgeon's screen children early to detect meningiomas before they advance into giant stages. Two years follow-up after surgery showed no tumor recurrence.
Source: Interdisciplinary Neurosurgery - Category: Neurosurgery Source Type: research
New medical breakthroughs are helping people suffering from hearing and vision problems. ... Tinnitus could be helped with a sound-therapy system.
Source: AARP.org News - Category: American Health Source Type: news
This study is a randomised controlled trial with a delayed treatment design. Patients with a TMD (TMD pain screener ≥ 3 points) or oral parafunctions (such as clenching and bruxism), who are suffering from moderate to severe subjective tinnitus (Tinnitus Functional Index (TFI) between 25 and 90 points), will be recruited from the tertiary tinnitus clinic of the University Hospital of Antwerp, Edegem, Belgium.Patients will be excluded in case of clear otological or neurological causes of the tinnitus, progressive middle ear pathology, intracranial pathology, traumatic cervical spine or temporomandibular injury in ...
Source: Trials - Category: Research Source Type: clinical trials
Conclusion Based on the results of the current study, we can conclude that the participants improved both the auditory perception and the tinnitus handicap. [...] Thieme Revinter Publicações Ltda Rio de Janeiro, BrazilArticle in Thieme eJournals: Table of contents  |  Abstract  |  open access Full text
Source: International Archives of Otorhinolaryngology - Category: ENT & OMF Authors: Tags: Original Research Source Type: research
Internet-based cognitive behavioral therapy (iCBT) is at least as effective as standard face-to-face clinical care for reducing distress due to tinnitus, new research shows.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Conditions:   Stress Disorders, Post-Traumatic;   Tinnitus Intervention:   Behavioral: Cognitive Processing Therapy (CPT) Sponsor:   The University of Texas Health Science Center at San Antonio Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Clinical Trials | Medical Devices | Neurology | Tinnitus | Venture Capital